Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Your exact dosing plan may vary based on your providers recommendations
Blue Crosss move is among the latest signs the surge in demand for GLP-1s, which doctors say provide broad health benefits to their patients, is pushing insurers and employers toward a financial breaking point
Tirzepatide belongs to a class called GIP GLP-1 medication
Isolating one variable at a time is the only way to know what actually helped
FIGURE 1 The prevalence of DED, which surged to as high as 61.0% during the COVID-19 pandemic (Ji et al., 2023), underscores the influence of increased exposure to visual display terminals and widespread mask usage during the pandemic, which likely exacerbated the condition by decreasing blink frequency and increasing thermal air currents over the ocular area, thus enhancing tear evaporation rates (Uwimana et al., 2022
ADA Meeting summary, 2024
US$ 29.12
US$ 29.90
US$ 27.86
US$ 27.32
US$ 27.74
